[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IE861099L - Azabicyclic compounds - Google Patents

Azabicyclic compounds

Info

Publication number
IE861099L
IE861099L IE861099A IE109986A IE861099L IE 861099 L IE861099 L IE 861099L IE 861099 A IE861099 A IE 861099A IE 109986 A IE109986 A IE 109986A IE 861099 L IE861099 L IE 861099L
Authority
IE
Ireland
Prior art keywords
alkyl
phenyl
cycloalkyl
alkoxy
halogen
Prior art date
Application number
IE861099A
Other versions
IE58313B1 (en
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26289173&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IE861099(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB858510752A external-priority patent/GB8510752D0/en
Priority claimed from GB858525913A external-priority patent/GB8525913D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of IE861099L publication Critical patent/IE861099L/en
Publication of IE58313B1 publication Critical patent/IE58313B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/12—Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compounds of formula (I) and pharmaceutically acceptable salts thereof: <CHEM> wherein X is CO and Y is NH or O, or X is NH and Y is CO; Z is CH2, O, S or NR3 wherein R3 is hydrogen, C1-6 alkyl, C3-7 alkenyl-methyl, phenyl or phenyl C1-4 alkyl either of which phenyl moieties may be substituted by one or two of halogen, CF3, C1-6 alkoxy or C1-6 alkyl; and Ra is not present; or Z is CH or N and Ra is as defined for R3 above; Rb is present when X-Y-R2 is attached at the phenyl ring and is selected from hydrogen, halogen, CF3, hydroxy, C1-6 alkoxy or C1-6 alkyl; R1 is hydrogen, halogen, CF3, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-7 acyl, C1-7 acylamino, C1-6 alkylsulphonylamino, N-(C1-6 alkylsulphonyl)-N-C1-4 alkylamino, C1-6 alkylsulphinyl, hydroxy, nitro or amino, aminocarbonyl, aminosulphonyl, aminosulphonylamino or N-(aminosulphonyl)-C1-4 alkylami- no optionally N-substituted by one or two groups selected from C1-6 alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl C1-4 alkyl, phenyl or phenyl C1-4 alkyl groups or optionally N-disubstituted by C4-5 polymethylene; R2 is a group of formula (a), (b) or (c) <CHEM> wherein n is 2 or 3; p and q are independently 1 to 3; and R4 or R5 is C1-7 alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl-c1-2 alkyl, or a group (CH2)tR6 where t is 1 or 2 and R6 thienyl, [EP0200444A2]
IE109986A 1985-04-27 1986-04-25 Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity IE58313B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858510752A GB8510752D0 (en) 1985-04-27 1985-04-27 Compounds
GB858525913A GB8525913D0 (en) 1985-10-21 1985-10-21 Compounds

Publications (2)

Publication Number Publication Date
IE861099L true IE861099L (en) 1986-10-27
IE58313B1 IE58313B1 (en) 1993-09-08

Family

ID=26289173

Family Applications (1)

Application Number Title Priority Date Filing Date
IE109986A IE58313B1 (en) 1985-04-27 1986-04-25 Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity

Country Status (17)

Country Link
US (2) US4886808A (en)
EP (2) EP0200444B1 (en)
JP (1) JP2696457B2 (en)
AU (1) AU594670B2 (en)
BG (1) BG61324B2 (en)
CA (1) CA1296004C (en)
CY (1) CY1721A (en)
CZ (1) CZ286325B6 (en)
DE (2) DE3650772T2 (en)
DK (1) DK170166B1 (en)
ES (1) ES8707948A1 (en)
GR (1) GR861103B (en)
HK (1) HK66993A (en)
IE (1) IE58313B1 (en)
NZ (1) NZ215945A (en)
PT (1) PT82463B (en)
SG (1) SG39393G (en)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650772T2 (en) * 1985-04-27 2003-04-03 F. Hoffmann-La Roche Ag, Basel Derivatives of indazole-3-carboxamide and -3-carboxylic acid
US4937247A (en) * 1985-04-27 1990-06-26 Beecham Group P.L.C. 1-acyl indazoles
GB8623142D0 (en) * 1986-09-26 1986-10-29 Beecham Group Plc Compounds
GB8515845D0 (en) * 1985-06-22 1985-07-24 Beecham Group Plc Treatment
US5204356A (en) * 1985-07-24 1993-04-20 Glaxo Group Limited Treatment of anxiety
GB8518658D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Medicaments
DE3687980T2 (en) * 1986-01-07 1993-06-17 Beecham Group Plc INDOLDER DERIVATIVES WITH AN AZABICYCLIC SIDE CHAIN, METHOD FOR THEIR PRODUCTION, INTERMEDIATE PRODUCTS AND PHARMACEUTICAL COMPOSITIONS.
DE3782107T2 (en) * 1986-07-25 1993-04-01 Beecham Group Plc AZABICYCLIC COMPOUNDS, METHOD FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE.
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
AT396870B (en) * 1986-08-07 1993-12-27 Sandoz Ag Process for the production of a pharmaceutical formulation for the nasal administration of serotonin antagonists
DE3777805D1 (en) * 1986-11-21 1992-04-30 Glaxo Group Ltd MEDICINES FOR TREATING OR PREVENTING THE WITHDRAWAL SYNDROME.
DE3788057T2 (en) * 1986-12-17 1994-03-03 Glaxo Group Ltd Use of heterocyclic compounds for the treatment of depression.
US5200414A (en) * 1986-12-17 1993-04-06 Glaxo Group Limited Methods for the treatment of cognitive disorders
US5190954A (en) * 1986-12-17 1993-03-02 Glaxo Group Limited Methods for the treatment of cognitive disorders
DE3752062T2 (en) * 1986-12-17 1997-09-11 Glaxo Group Ltd Use of heterocyclic derivatives for the manufacture of drugs
GB8806990D0 (en) * 1988-03-23 1988-04-27 Beecham Group Plc Novel compounds
GB8701022D0 (en) * 1987-01-19 1987-02-18 Beecham Group Plc Treatment
EP0287196B1 (en) * 1987-02-18 1994-11-23 Beecham Group Plc Indole derivatives, process for their preparation and pharmaceutical compositions containing them
DE3876006T2 (en) * 1987-04-14 1993-03-25 Glaxo Group Ltd KETONE DERIVATIVES.
DE3881950T2 (en) 1987-04-25 1993-09-30 Beecham Group Plc Azabicyclic compounds, processes for their preparation and pharmaceutical preparations containing them.
DE3822792C2 (en) * 1987-07-11 1997-11-27 Sandoz Ag New use of 5HT¶3¶ antagonists
GB8723157D0 (en) * 1987-10-02 1987-11-04 Beecham Group Plc Compounds
AU616706B2 (en) * 1987-11-14 1991-11-07 Beecham Group Plc 5-ht3 receptor antagonists for treatment of cough and bronchoconstriction
IE63474B1 (en) * 1987-12-24 1995-04-19 Wyeth John & Brother Ltd Heterocyclic compounds
US4950759A (en) * 1988-07-07 1990-08-21 Duphar International Research B.V. Substituted 1,7-annelated 1H-indazoles
US5166341A (en) * 1988-07-29 1992-11-24 Dainippon Pharmaceutical Co., Ltd. 6-amino-1,4-hexahydro-1H-diazepine derivatives
US5017573A (en) * 1988-07-29 1991-05-21 Dainippon Pharmaceutical Co., Ltd. Indazole-3-carboxylic acid derivatives
CA2004911A1 (en) * 1988-12-22 1990-06-22 Mitsuaki Ohta 4,5,6,7-tetrahydrobenzimidazole derivatives
ATE144511T1 (en) * 1989-02-02 1996-11-15 Yamanouchi Pharma Co Ltd TETRAHYDROBENZIMIDAZOLE DERIVATIVES
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds
GB8916682D0 (en) * 1989-07-21 1989-09-06 Beecham Group Plc Pharmaceutical compounds
US4992461A (en) * 1989-09-11 1991-02-12 G. D. Searle & Co. N-azabicyclo(3.3.0)octane amides of aromatic acids, compositions, and methods of use thereof
US5126343A (en) * 1989-09-11 1992-06-30 G. D. Searle & Co. N-azabicyclo [3.3.0]octane amides of aromatic acids
US5180728A (en) * 1989-09-25 1993-01-19 Fujisawa Pharmaceutical Company, Ltd. Pyrimidoindole derivatives and processes for preparation thereof
US5225419A (en) * 1989-10-14 1993-07-06 John Wyeth & Brother, Limited Certain 1,8-ethano or propano-1,4-dihydro-4-oxo-quinoline-3-carboxamides and derivatives thereof
GB8923209D0 (en) * 1989-10-14 1989-11-29 Wyeth John & Brother Ltd Heterocyclic compounds
GB2236751B (en) 1989-10-14 1993-04-28 Wyeth John & Brother Ltd Heterocyclic compounds
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
GB9009389D0 (en) * 1990-04-26 1990-06-20 Smith Kline French Lab Treatment
GB9009542D0 (en) * 1990-04-27 1990-06-20 Beecham Group Plc Novel compounds
AU7618991A (en) * 1990-05-14 1991-11-14 Syntex (U.S.A.) Inc. Novel tricyclic compounds
US5202318A (en) * 1990-05-14 1993-04-13 Syntex (U.S.A.) Inc. Tricyclic compounds acting at serotonin receptor subtypes
JP3122671B2 (en) * 1990-05-23 2001-01-09 協和醗酵工業株式会社 Heterocyclic compounds
GB9020927D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Pharmaceuticals
US5200415A (en) * 1990-11-01 1993-04-06 Asahi Kasei Kogyo Kabushiki Kaisha Pyrazolo[1,5-a]pyridine-3-carboxylic acid derivatives and their pharmaceutical use
HU211081B (en) * 1990-12-18 1995-10-30 Sandoz Ag Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same
GB9101221D0 (en) * 1991-01-19 1991-02-27 Smithkline Beecham Plc Pharmaceuticals
US5929059A (en) * 1991-01-19 1999-07-27 Smithkline Beecham P.L.C. Pharmaceutical compositions containing granisetron and dexamethasone
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
US5225412A (en) * 1991-04-29 1993-07-06 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5492919A (en) * 1991-08-03 1996-02-20 Smithkline Beecham P.L.C. 5-HT4 receptor antagonists
WO1993003725A1 (en) * 1991-08-20 1993-03-04 Smithkline Beecham Plc 5-ht4 receptor antagonists
JPH0557982A (en) * 1991-09-02 1993-03-09 Canon Inc Carriage drive
DK0533280T4 (en) 1991-09-20 2005-02-28 Glaxo Group Ltd New medical use of tachykinin antagonists
WO1993014745A1 (en) * 1992-01-23 1993-08-05 Smithkline Beecham Plc Use of 5-ht4 receptor antagonists as medicaments for treating migraine
US5344831A (en) * 1992-01-31 1994-09-06 Nisshin Flour Milling Co., Ltd. Diazabicyclo derivatives
JP2699794B2 (en) * 1992-03-12 1998-01-19 三菱化学株式会社 Thieno [3,2-b] pyridine derivative
US5236931A (en) * 1992-03-26 1993-08-17 A. H. Robins Company, Incorporated 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine and 3-quinuclidinol
GR1001378B (en) * 1992-10-08 1993-10-29 Smithkline Beecham Plc Pharmaceutical compounds.
ES2056728B1 (en) * 1992-10-28 1995-05-01 Smithkline Beecham Plc NEW PIPERIDILE AND AMINOALKYL DERIVATIVES WITH ANTAGONIST ACTIVITY OF THE 5-HT4 RECEPTOR
GB9305593D0 (en) * 1993-03-18 1993-05-05 Smithkline Beecham Plc Pharmaceuticals
CN1039623C (en) * 1993-10-22 1998-09-02 中国人民解放军军事医学科学院毒物药物研究所 Pharmaceutical composition for preventing and treating motion sickness syndrome and preparation method thereof
GB9404055D0 (en) * 1994-03-03 1994-04-20 Smithkline Beecham Plc Novel process
GB9406857D0 (en) * 1994-04-07 1994-06-01 Sandoz Ltd Improvements in or relating to organic compounds
GB9412995D0 (en) * 1994-06-28 1994-10-26 Prendergast Kenneth F Safety enhancing pharmaceutical compositions of an active indazole
DE69524113D1 (en) * 1994-09-29 2002-01-03 Idemitsu Petrochemical Co METHOD FOR PRODUCING MONOCARBONIC AND / OR DICARBONIC ACIDS
GB9502582D0 (en) * 1995-02-10 1995-03-29 Smithkline Beecham Plc Novel process
GB9502583D0 (en) * 1995-02-10 1995-03-29 Smithkline Beecham Plc Novel process
ES2124162B1 (en) * 1995-03-01 1999-11-16 Smithkline Beecham Plc A NEW PROCEDURE FOR PREPARING PHARMACEUTICALLY ACTIVE COMPOUNDS.
GB9504078D0 (en) * 1995-03-01 1995-04-19 Smithkline Beecham Plc Novel process
GB9506119D0 (en) * 1995-03-25 1995-05-10 Smithkline Beecham Plc Chemical process
US5880121A (en) * 1996-01-05 1999-03-09 Hoechst Marion Roussel Inc. 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof
GB9602866D0 (en) 1996-02-13 1996-04-10 Smithkline Beecham Plc Novel process
GB9602862D0 (en) * 1996-02-13 1996-04-10 Smithkline Beecham Plc Novel process
US6294548B1 (en) * 1998-05-04 2001-09-25 Hoffmann-La Roche Inc. Multidose vial formulations for administering endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
JP2000198734A (en) * 1998-12-30 2000-07-18 Pfizer Inc Motility enhancers for the treatment of gastric motility impairment and related disorders
KR20010112673A (en) * 2000-06-09 2001-12-21 김환기 Preparation of Tropisetron HCl
ES2197001B1 (en) 2002-03-26 2004-11-16 Laboratorios Vita, S.A. PROCEDURE FOR OBTAINING A PHARMACEUTICALLY ACTIVE COMPOUND.
KR101129933B1 (en) * 2002-09-25 2012-03-23 메모리 파마슈티칼스 코포레이션 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
WO2004045615A1 (en) * 2002-11-15 2004-06-03 Helsinn Healthcare Sa Palonosetron for the treatment of chemotherapy-induced emesis
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
TWI355936B (en) 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
US7060841B2 (en) 2003-06-03 2006-06-13 Chemagis Ltd. Process for preparing 1-methylindazole-3-carboxylic acid
RS20060391A (en) 2003-12-22 2008-11-28 Memory Pharmaceuticals Corporation, Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2- benzisothiazoles, and preparation and uses thereof
US20060167072A1 (en) * 2004-01-30 2006-07-27 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
EP2336128A1 (en) 2004-03-25 2011-06-22 Memory Pharmaceuticals Corporation Benzoisothiazoles and preparation and uses thereof
ATE487716T1 (en) 2004-04-22 2010-11-15 Memory Pharm Corp INDOLES, 1H-INDAZOLES, 1,2-BENZISOXAZOLES, 1,2-BENZOISOTHIAZOLES, THEIR PRODUCTION AND USES
NZ551712A (en) * 2004-05-07 2010-07-30 Memory Pharm Corp 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparations and uses thereof
DE602005019094D1 (en) 2004-12-22 2010-03-11 Memory Pharmaceutical Corp NICOTINE ALPHA-7 RECEPTOR LIGANDS AGAINST DISEASES OF THE CNS
MX2007007818A (en) * 2004-12-22 2007-09-11 Theravance Inc Indazole-carboxamide compounds.
US7868016B2 (en) 2005-07-13 2011-01-11 Baxter International Inc. Pharmaceutical formulations of endo-N-(9-methyl-9-azabicyclo[3,3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
US8106066B2 (en) 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
US8911751B2 (en) 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
WO2007054784A1 (en) * 2005-11-10 2007-05-18 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of granisetron hydrochloride
WO2007088557A1 (en) * 2006-02-01 2007-08-09 Natco Pharma Limited Process for highly pure crystalline granisetron base
US20080004260A1 (en) * 2006-06-29 2008-01-03 Transcept Pharmaceuticals, Inc. Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions
UA97653C2 (en) * 2006-10-24 2012-03-12 Хелсинн Хелткер С.А. Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability
ITMI20062230A1 (en) 2006-11-22 2008-05-23 Acraf 2-ALCHIL-INDAZOLIC COMPOUND PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
US8304426B2 (en) 2007-06-13 2012-11-06 Inke, S.A. Polymorphic form of Granisetron base, methods for obtaining it and formulation containing it
US20100298397A1 (en) * 2009-05-19 2010-11-25 Singh Nikhilesh N Method of treatment of obsessive compulsive disorder with ondansetron
EP2253316B1 (en) 2009-05-20 2013-08-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits
KR101779991B1 (en) 2009-05-20 2017-09-19 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders
JOP20130213B1 (en) * 2012-07-17 2021-08-17 Takeda Pharmaceuticals Co Oppositions to the 5-HT3 Future
HUE055175T2 (en) 2014-09-29 2021-11-29 Takeda Pharmaceuticals Co Crystalline form of 1-(1-methyl-1h-pyrazol-4-yl)-n-((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-1h-indole-3-carboxamide
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
CA2996717A1 (en) 2015-09-11 2017-03-16 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100909A1 (en) * 1970-07-15 1972-03-24 Egyt Gyogyszervegyeszeti Gyar Indazole-3-carboxylic acid amides - prodn from corres acids analgesics and antiinflammatories
GB2100259B (en) * 1981-06-13 1984-10-31 Merrell Toraude & Co Treatment of migraine with tropyl benzoate derivatives
FR2531083B1 (en) * 1982-06-29 1986-11-28 Sandoz Sa NOVEL PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINES
FR2548666A1 (en) * 1983-07-08 1985-01-11 Delalande Sa New nortropane and granatane derivatives, process for their preparation and their application in therapeutics
DE3429830A1 (en) * 1983-08-26 1985-03-07 Sandoz-Patent-GmbH, 7850 Lörrach AUTOMATIC CARBONIC ACID AND SULPHONIC ACID ESTERS OR AMIDES
GB8510752D0 (en) * 1985-04-27 1985-06-05 Beecham Group Plc Compounds
GB8525913D0 (en) * 1985-10-21 1985-11-27 Beecham Group Plc Compounds
DE3650772T2 (en) * 1985-04-27 2003-04-03 F. Hoffmann-La Roche Ag, Basel Derivatives of indazole-3-carboxamide and -3-carboxylic acid
US4937247A (en) * 1985-04-27 1990-06-26 Beecham Group P.L.C. 1-acyl indazoles
GB8520616D0 (en) * 1985-08-16 1985-09-25 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
NZ215945A (en) 1990-04-26
US4886808A (en) 1989-12-12
CY1721A (en) 1994-05-06
CA1296004C (en) 1992-02-18
JPH05194508A (en) 1993-08-03
EP0200444B1 (en) 1992-11-11
DE3687080D1 (en) 1992-12-17
EP0200444A2 (en) 1986-11-05
ES554405A0 (en) 1987-09-01
EP0498466A1 (en) 1992-08-12
DE3650772D1 (en) 2002-08-29
US5034398A (en) 1991-07-23
AU594670B2 (en) 1990-03-15
EP0200444A3 (en) 1988-12-14
PT82463B (en) 1988-10-14
BG61324B2 (en) 1997-05-30
JP2696457B2 (en) 1998-01-14
SG39393G (en) 1993-06-11
HK66993A (en) 1993-07-16
PT82463A (en) 1986-05-01
DE3650772T2 (en) 2003-04-03
GR861103B (en) 1986-08-11
IE58313B1 (en) 1993-09-08
AU5657986A (en) 1986-11-06
CS332391A3 (en) 1992-06-17
DK191186A (en) 1986-10-28
CZ286325B6 (en) 2000-03-15
DE3687080T2 (en) 1993-03-25
DK191186D0 (en) 1986-04-24
DK170166B1 (en) 1995-06-06
ES8707948A1 (en) 1987-09-01
EP0498466B1 (en) 2002-07-24

Similar Documents

Publication Publication Date Title
IE861099L (en) Azabicyclic compounds
IE870013L (en) Azabicyclo (3.2.1. or 2.2.2.) oct-3-yl-indole derivatives
EP0235878A3 (en) Novel compounds
EP0315390A3 (en) Novel compounds
IE792524L (en) Azabicycloalkyl derivatives.
ES8500271A1 (en) Bicyclic benzamides or anilides, process for their preparation, and pharmaceutical compositions containing them.
IE882869L (en) Benzimidazoline-2-oxo-1-carboxylic acid derivatives
ES8404349A1 (en) Nortropyl benzopyrrolinone compounds, process for their preparation and pharmaceutical compositions containing them.
NO164476C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 1,2,3,5-TETRAHYDROIMIDAZO- (2,1-B) -KINAZOLINES.
CA2247443A1 (en) Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
CA2197298A1 (en) Novel Pyrimidine Derivatives and Processes for the Preparation Thereof
ES8203364A1 (en) Aniline derivatives.
IL95440A0 (en) Substituted urea compounds,their preparation and pharmaceutical compositions containing them
ES8307244A1 (en) Azobicycloalkylbenzamides, process for their preparation and pharmaceutical compositions containing them.
NO895023L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINE DERIVATIVES.
DE69127072D1 (en) SUBSTITUTED UREAS, PRODUCTION AND USE
AU8445591A (en) N-(mercaptoalkyl)ureas and carbamates
IE894039L (en) Therapeutic agents
CA2373944A1 (en) Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
IE812890L (en) Benzodiazepine compounds
ES8306752A1 (en) Pharmaceutically active compounds.
PT1021404E (en) AZETIDINONE DERIVATIVES FOR THE TREATMENT OF INFECTIONS BY HCMV
NO165801C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-ACYLAMINOMETHYLIMIDAZO- (1,2-A) -KINOLINES.
ES8403899A1 (en) Process for the preparation of new benzamide derivatives

Legal Events

Date Code Title Description
MK9A Patent expired